EIG
Evercore ISI Group Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
201
Teladoc Health
TDOC
$1.38B
|
EA
Elizabeth Anderson
| $7.82 | $8 |
2%
upside
| In-Line |
9 Jul ‘25
2 months ago |
|
202
Privia Health
PRVA
$2.87B
|
EA
Elizabeth Anderson
| $23.40 | $28 |
20%
upside
| Outperform |
9 Jul ‘25
2 months ago |
|
|
OMDA
203
Omada Health, Inc. Common Stock
OMDA
$1.35B
| $23.38 | $23 |
2%
downside
| Outperform |
9 Jul ‘25
2 months ago |
|
|
204
Envista
NVST
$3.49B
|
EA
Elizabeth Anderson
| $21 | $23 |
10%
upside
| Outperform |
9 Jul ‘25
2 months ago |
|
205
McKesson
MCK
$86.1B
|
EA
Elizabeth Anderson
| $692.04 | $800 |
16%
upside
| Outperform |
9 Jul ‘25
2 months ago |
|
206
IQVIA
IQV
$31.8B
|
EA
Elizabeth Anderson
| $187.10 | $180 |
4%
downside
| Outperform |
9 Jul ‘25
2 months ago |
|
207
AZZ Inc
AZZ
$3.46B
|
SR
Stephen Richardson
| $115.12 | $108 |
6%
downside
| Outperform |
9 Jul ‘25
2 months ago |
|
208
Align Technology
ALGN
$9.92B
| $136.83 | $220 |
61%
upside
| Outperform |
9 Jul ‘25
2 months ago |
|
|
209
Agilon Health
AGL
$526M
|
EA
Elizabeth Anderson
| $1.27 | $3 |
136%
upside
| In-Line |
9 Jul ‘25
2 months ago |
|
210
Doximity
DOCS
$13.1B
|
EA
Elizabeth Anderson
| $70.05 | $70 |
0%
downside
| Outperform |
9 Jul ‘25
2 months ago |
|
211
Zimmer Biomet
ZBH
$20.7B
|
VK
Vijay Kumar
| $104.45 | $96 |
8%
downside
| In-Line |
8 Jul ‘25
2 months ago |
|
212
Thermo Fisher Scientific
TMO
$183B
|
VK
Vijay Kumar
| $485.64 | $480 |
1%
downside
| Outperform |
8 Jul ‘25
2 months ago |
|
213
Stryker
SYK
$150B
|
VK
Vijay Kumar
| $391.75 | $415 |
6%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
214
Revvity
RVTY
$9.99B
|
VK
Vijay Kumar
| $86.03 | $115 |
34%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
215
Repligen
RGEN
$6.78B
|
DM
Daniel Markowitz
| $120.47 | $130 |
8%
upside
| In-Line |
8 Jul ‘25
2 months ago |
|
216
Medtronic
MDT
$119B
|
VK
Vijay Kumar
| $92.64 | $106 |
14%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
217
Jasper Therapeutics
JSPR
$42.6M
|
GC
Gavin Clark-Gartner
| $2.62 | $20 |
663%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
218
Intuitive Surgical
ISRG
$168B
|
VK
Vijay Kumar
| $468.50 | $550 |
17%
upside
| In-Line |
8 Jul ‘25
2 months ago |
|
219
Illumina
ILMN
$15.5B
|
VK
Vijay Kumar
| $97.86 | $128 |
31%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
220
Hologic
HOLX
$14.7B
|
VK
Vijay Kumar
| $66.19 | $68 |
3%
upside
| In-Line |
8 Jul ‘25
2 months ago |
|
221
Enovis
ENOV
$1.79B
|
VK
Vijay Kumar
| $31.27 | $46 |
47%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
222
Danaher
DHR
$142B
|
VK
Vijay Kumar
| $197.73 | $226 |
14%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
223
Bausch + Lomb
BLCO
$5.47B
|
VK
Vijay Kumar
| $15.45 | $16 |
4%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
224
Baxter International
BAX
$12.3B
|
VK
Vijay Kumar
| $23.89 | $42 |
76%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|
225
Abbott
ABT
$230B
|
VK
Vijay Kumar
| $131.95 | $145 |
10%
upside
| Outperform |
8 Jul ‘25
2 months ago |
|